Major shareholding notification
Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 25 percent shareholding. Through a recent directed issue, ShapeQ GmbH has acquired 1,000,000 shares which means a total holding of shares is 4,296,438 after the direct issue transaction, corresponding to approximately 26.1 percent of the votes and capital in Redsense Medical AB. Contact information For more information, please contact: Jennie Kardell, CEOTelephone: +46 72-171 1264E-mail: jennie.kardell (at) redsensemedical.com Redsense Medical AB (publ), 556646-4862